BeiGene Ltd. (49B) — Cash Flow Reinvestment Rate

Latest as of March 2025: 5.41x

BeiGene Ltd. (49B) has a Cash Flow Reinvestment Rate of 5.41x as of March 2025, reinvesting €238.35 Million (capex €116.41 Million plus investments €-121.94 Million) from operating cash flow of €44.08 Million. Explore BeiGene Ltd. capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

5.41x
(Capex + Investments) / Operating CF

Total Reinvested

€238.35 Million
Capex + Investments

Operating Cash Flow

€44.08 Million
EUR

Capital Expenditures

€116.41 Million
EUR

BeiGene Ltd. Cash Flow Reinvestment Rate (2017–2017)

Historical reinvestment intensity for BeiGene Ltd. across 1 annual periods. Also explore BeiGene Ltd. asset portfolio for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for BeiGene Ltd. (2017–2017)

Year-by-year capital reinvestment analysis for BeiGene Ltd.. For live market cap and broader valuation context, see BeiGene Ltd. stock valuation.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2017 28.54x €363.88 Million €12.75 Million €46.37 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow